• Lifesaving innovations

    We are creating medical devices that can revolutionise healthcare in the world. We are connecting vast medical knowledge with technical skills to make difference in the world and in life of patients.

    Read more
  • Breast Cancer Diagnostics

    Meet our innovative project, future of breast cancer diagnostics. We want to save up to 30% of people diagnosed with cancer by year 2030!

    More about inPROBE
  • Lifesavings innovations

    We are creating medical devices that can revolutionise healthcare in the world. We are connecting vast medical knowledge with technical skills to make make difference in the world and in life of patients.

Latest news

Nomination for Economic Award by Money.pl & Next Health Pitch Investment

We had a great pleasure to be nominated for Economic Award presented by Money.pl Editorial Staff. It was first edition of the Money.pl award has been launched. SDS Optic was in grand final with 11 companies like: CD Projekt, Synthos, Dom Development, Eobuwie. Judges has chosen companies and technologies that are going to shape

Euronext 2019 Paris

European Innovation Council (EIC), as part of Business Acceleration Services for its selected SME Instrument funded project, has invited TOP40 selected fast-growing DeepTech SMEs for a scaling up day at Euronext HQ in Paris La Dafense

Central European CEBIO Forum 2019

The objective of the Central European BioForum is to present Polish biotechnological sector to foreign investors and encourage their engagement. At yesterday's edition SDS Optic CEO Marcin Staniszewski took part in discussion

Top 500 Innovators Meet Up, Wroclaw

Since 2011 alumni of the Top500 Innovators Programme have organized meet up to boost cooperation between science and business. SDS Optic team was invited by organizers as main lecturers. We've taken part in discussion panels. Magdalena Staniszewska and Marcin Staniszewski were main speakers at MedTech-related startup technology debate.

European Innovation Council Roadshow Warsaw 2019

Last week we were present at European Innovation Council Roadshow in Warsaw. We've been talking about new funding opportunities and inPROBE project as a flagship HORIZON 2020 beneficiary from Poland. Mateusz Sagan our Chieff Business Officer has taken part in panel and Q&A discussion



Know more about inPROBE technology

SDS Optic develops and creates innovative solutions on the borderline of biochemistry, engineering and fibre optic technologies, that can be used in cancer diagnosis and treatment. Company designed a revolutionary opto-biological methodology that allows for instant cellular processes studies including in-vivo cancer diagnosis with single-cell resolution. inPROBE detects presence and measures concentration levels of the HER+ cancer cells in breast tumours.

 

Who we are

The SDS Optic team is working on a breakthrough technology based on rapid detection of the test substance in the body, including cancer markers, with particular accuracy, the use of laser beams and the use of innovative components. At the end of the process, the reading is interpreted on the detector using an appropriate conversion algorithm, which gives the level of the tested compound (e.g. HER2 cancer marker) in a numerical form. 

Our technology is a breakthrough. We create inPROBE a tool for direct measurement of the HER2 marker. The use of a microsonde will save the patient pain and stress associated with biopsy and waiting for the result. We want to save up to 30% of people diagnosed with cancer by year 2030



Our partners